* Apyx Medical Corp reported a quarterly adjusted loss of 14 cents per share for the quarter ended September 30, lower than the same quarter last year, when the company reported EPS of -13 cents. The mean expectation of five analysts for the quarter was for a loss of 19 cents per share. Wall Street expected results to range from -23 cents to -15 cents per share.
* Revenue fell 4.1% to $11.49 million from a year ago; analysts expected $11.38 million.
* Apyx Medical Corp's reported EPS for the quarter was a loss of 14 cents.
* The company reported a quarterly loss of $4.7 million.
* Apyx Medical Corp shares had fallen by 1.6% this quarter and lost 53.4% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had fallen by about 0.3% in the last three months.
* In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 2 "strong buy" or "buy," 3 "hold" and no "sell" or "strong sell."
* The average consensus recommendation for the medical equipment, supplies & distribution peer group is also "hold"
Wall Street's median 12-month price target for Apyx Medical Corp is $2.50 This summary was machine generated from LSEG data November 8 at 04:15 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Sep. 30 2024 -0.19 -0.14 Beat
Jun. 30 2024 -0.20 -0.19 Beat
Mar. 31 2024 -0.21 -0.22 Missed
Dec. 31 2023 -0.18 -0.28 Missed
Comments